Detection of the EGFR mutation in exhaled breath condensate from a heavy smoker with squamous cell carcinoma of the lung

Lung Cancer

Volumn 73, Issue 3, 2011, Pages 379-380

  Zhang, Dan ^a   Takigawa, Nagio ^b   Ochi, Nobuaki ^a   Tanimoto, Yasushi ^a   Noujima, Daisuke ^a   Chen, Yan Yan ^a   Tanimoto, Mitsune ^a   Kiura, Katsuyuki ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

EGFR; Exhaled breath condensate; Gefitinib; Heavy smoker; Non small cell lung cancer; Squamous cell carcinoma

Indexed keywords

CIGARETTE SMOKE CONDENSATE; DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; EXHALED BREATH CONDENSATE; GEFITINIB; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRAIN METASTASIS; BRAIN RADIATION; BRONCHOSCOPY; CANCER REGRESSION; CASE REPORT; CIGARETTE SMOKING; COMPUTER ASSISTED TOMOGRAPHY; DELETION MUTANT; DNA EXTRACTION; EXON; FLEXIBLE BRONCHOSCOPY; GENE MUTATION; HUMAN; LUNG SQUAMOUS CELL CARCINOMA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARALYSIS; PRIORITY JOURNAL; THORAX PAIN; THORAX RADIOGRAPHY; TRANSBRONCHIAL BIOPSY;

BRAIN NEOPLASMS; BREATH TESTS; CARCINOMA, SQUAMOUS CELL; DNA MUTATIONAL ANALYSIS; EXHALATION; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; QUINAZOLINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; REMISSION INDUCTION; SEQUENCE DELETION; SMOKING;

EID: 79960890849     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2011.05.018     Document Type: Article

References (10)

1. Shigematsu H., Lin L., Takahashi T., Nomura M., Suzuki M., Wistuba I.I., et al. Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. J Natl Cancer Inst 2005, 97:339-346.
2. Mitsudomi T., Morita S., Yatabe Y., Negoro S., Okamoto I., Tsurutani J., et al. Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial. Lancet Oncol 2010, 11:121-128.
3. Maemondo M., Inoue A., Kobayashi K., Sugawara S., Oizumi S., Isobe H., et al. Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR. N Engl J Med 2010, 362:2380-2388.
4. Ueno T., Kataoka M., Hirano A., Iio K., Tanimoto Y., Kanehiro A., et al. Inflammatory markers in exhaled breath condensate from patients with asthma. Respirology 2008, 13:654-663.
5. Chorostowska-Wynimko J., Szpechcinski A. The impact of genetic markers on the diagnosis of lung cancer: a current perspective. J Thorac Oncol 2007, 2:1044-1051.
6. Nagai Y., Miyazawa H., Huqun, Tanaka T., Udagawa K., Kato M., et al. Genetic heterogeneity of the epidermal growth factor receptor in non-small cell lung cancer cell lines revealed by a rapid and sensitive detection system, the peptide nucleic acid-locked nucleic acid PCR clamp. Cancer Res 2005, 65:7276-7282.
7. Paradiso A., Tommasi S., Pinto R., Carpagnano G.E., Foschino-Barbaro M.P. Exhaled breath condensate is not suitable to detect EGFR somatic mutations. Eur Respir J 2008, 32:1126-1127.
8. Tanaka T., Nagai Y., Miyazawa H., Koyama N., Matsuoka S., Sutani A., et al. Reliability of the peptide nucleic acid-locked nucleic acid polymerase chain reaction clamp-based test for epidermal growth factor receptor mutations integrated into the clinical practice for non-small cell lung cancers. Cancer Sci 2007, 98:246-252.
9. Takano T., Ohe Y., Tsuta K., Fukui T., Sakamoto H., Yoshida T., et al. Epidermal growth factor receptor mutation detection using high-resolution melting analysis predicts outcomes in patients with advanced non small cell lung cancer treated with gefitinib. Clin Cancer Res 2007, 13:5385-5390.
10. Savic S., Tapia C., Grilli B., Rufle A., Bihl M.P., de Vito Barascud A., et al. Comprehensive epidermal growth factor receptor gene analysis from cytological specimens of non-small-cell lung cancers. Br J Cancer 2008, 98:154-160.